Please select the option that best describes you:

How can we approach tapering or discontinuing biologic DMARDs in patient in their 80s with well controlled rheumatoid arthritis?  



Answer from: at Academic Institution
Comments
at Arthritis Associates
One idea that I have tried with some patients (I r...
Sign In or Register to read more

Answer from: at Community Practice
Sign In or Register to read more

Answer from: at Academic Institution
Comments
at U.S. Department of Veterans Affairs
Yeah i agree seropos and erosive more risky, usual...
Sign In or Register to read more